华北制药：2025年半年度净利润约1.23亿元，同比增加71.56%

Core Insights - North China Pharmaceutical reported a revenue of approximately 5.275 billion yuan for the first half of 2025, representing a year-on-year increase of 0.84% [2] - The net profit attributable to shareholders of the listed company was approximately 123 million yuan, showing a significant year-on-year increase of 71.56% [2] - Basic earnings per share reached 0.072 yuan, which is an increase of 71.43% compared to the previous year [2]